Rosemont Pharmaceuticals Limited

Rosemont House, Yorkdale Industrial Park, Braithwaite Street, Leeds, Yorkshire, LS11 9XE
Telephone: +44 (0)113 244 1400
Fax: +44 (0)113 246 0738
WWW: http://www.rosemontpharma.com
Customer Care direct line: +44 (0)800 919 312
Out of Hours Telephone: +44 (0)7836 557 879
Out of Hours contact: pharmacovigilance@rosemontpharma.com

Patient Information Leaflet last updated on the eMC: 14/03/2011
PIL Soltamox 10mg/5ml Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 14/03/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to drug interactions
Updated on 17/08/2009 and displayed until 14/03/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
Updated on 13/03/2006 and displayed until 17/08/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to drug interactions
  • Change to information about pregnancy or lactation
  • Change to date of revision
Updated on 21/09/2005 and displayed until 13/03/2006
Reasons for adding or updating:
  • Change of contra-indications
  • Change to information about driving or using machinery
  • Change to date of revision
Updated on 24/11/2003 and displayed until 21/09/2005
Reasons for adding or updating:
  • Update to PIL
Updated on 05/03/2003 and displayed until 24/11/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 10/12/2001 and displayed until 05/03/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   tamoxifen citrate